- 8
- 0
- 约2.89万字
- 约 5页
- 2018-08-19 发布于天津
- 举报
儿童肾移植免疫抑制治疗中激素应用的变迁-肾脏病与透析肾移植杂志
·486 · J Nephrol Dialy Transplant Vol.26 No.5 Oct.2017
·肾脏移植 ·
儿童肾移植免疫抑制治疗中激素应用的变迁
满芯悦 综述 徐 虹 审校
摘 要 肾移植现已成为儿童肾脏替代治疗的“金标准”,为防止移植物排斥反应,免疫抑制治疗必不可少。
激素凭借其强大的抗炎及免疫抑制效应,一直是肾移植免疫抑制方案中必备药物,但长期应用激素的副作用对于
儿童群体尤其需要重视。 随着儿童肾移植的发展,免疫抑制治疗药物的不断更新,近十几年来各中心都在积极探
索适用于肾移植儿童的激素撤减的免疫抑制治疗方案,目前无激素/ 早期激素撤减方案已获多方肯定。
关键词 肾移植 儿童 免疫抑制 激素
Transition of steroids application in pediatric renal transplantation immunosuppression
MAN Xinyue,XUHong
Nephrology Department,Childrens Hospital of Fudan University,Shanghai Kidney Development & Pediatric Kidney Disease
Research Center,Shanghai 201102,China
ABSTRACT Renal transplantation has become the “Gold standard” of pediatric renal replacement therapies. In
order to prevent rejectionreactions,immunosuppression alwayskeepstransplantationscompany. Steroidsplayed avital role
in immunosuppressiveprotocols,becauseofitsstronganti⁃inflammatoryandimmunosuppressiveefficacy.However,theside
effects of long⁃term steroids applying must be stressed, especially in children. Immunosuppressive regimens change
following the development of pediatric renal transplantation. Many centers attempted to explore the proper ways of steroids
minimization therapiesfor children over the decades,and it has been approved that the steroids⁃avoidant/ early steroids⁃
withdrawal protocol is safe and efficacious.
Key words renal transplantation children immunosuppression steroids
肾病患儿5年生存率为95%,而接受血液透析和腹
背 景
[5]
膜透析的患儿5年生存率分别为76%和81% 。
儿童肾移植 肾移植是终末期肾病患儿目前最 免疫抑制治疗 KDIGO有关肾移植受者诊疗
具经济效益且最有效的治疗方式,相较于长期透析
原创力文档

文档评论(0)